These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3534868)

  • 41. [Rebound hypertension after controlled hypotension and its prevention by captopril].
    Pasch T; Kleierl-Lindner C; Götz H; Pichl J
    Anaesthesist; 1986 Feb; 35(2):66-72. PubMed ID: 3083712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aldosterone and renin in essential hypertension.
    Genest J; Nowaczynski W; Boucher R; Kuchel O; Rojo-Ortega JM
    Can Med Assoc J; 1975 Sep; 113(5):421-31. PubMed ID: 1098756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal renin short feedback loop in essential hypertension is reversible with converting enzyme inhibition.
    LeBoff Ms; Dluhy RG; Hollenberg NK; Moore TJ; Koletsky RJ; Williams GH
    J Clin Invest; 1982 Aug; 70(2):335-41. PubMed ID: 6284799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The renin-angiotensin system in hypothyroidism of short duration.
    Elias AN; Kyaw T; Valenta LJ; Meshkinpour H
    Horm Metab Res; 1986 May; 18(5):349-51. PubMed ID: 3522392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preventive effect of captopril on the development of experimental hypertension in rats.
    Petkov O; Mihailova-Todorova S; Kolarova R; Ankov V
    Acta Physiol Pharmacol Bulg; 1988; 14(4):20-6. PubMed ID: 3072834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of converting enzyme inhibition on blood pressure, plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension.
    Sullivan PA; Kelleher M; Twomey M; Dineen M
    J Hypertens; 1985 Aug; 3(4):359-63. PubMed ID: 2995484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
    Niutta E; Cusi D; Colombo R; Pellizzoni M; Cesana B; Barlassina C; Soldati L; Bianchi G
    J Hypertens Suppl; 1990 Sep; 8(4):S53-8. PubMed ID: 2175354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.
    Beretta-Piccoli C; Ziegler WH; Antonini P; Bernasconi-Zapf M; Kressebuch H; Pianezzi F
    J Hypertens; 1990 Jul; 8(7):671-8. PubMed ID: 2168458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose response in captopril therapy of hypertension.
    Lijnen P; Fagard R; Staessen J; Verschueren LJ; Amery A
    Clin Pharmacol Ther; 1980 Sep; 28(3):310-5. PubMed ID: 6250759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.
    Staessen J; Lijnen P; Fagard R; Verschueren LJ; Amery A
    J Endocrinol; 1981 Dec; 91(3):457-65. PubMed ID: 7035596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Captopril in the treatment of hypertension in type I and type II diabetic patients.
    D'Angelo A; Sartori L; Gambaro G; Giannini S; Malvasi L; Benetollo P; Lavagnini T; Crepaldi G
    Postgrad Med J; 1986; 62 Suppl 1():69-72. PubMed ID: 3534866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies on the pathophysiology of pregnancy induced hypertension--endocrinological analysis by the method of angiotensin II and NaCl loading].
    Yamasaki M; Morikawa H; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2315-24. PubMed ID: 3908589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.
    Saruta T; Suzuki H; Handa M; Igarashi Y; Kondo K; Senba S
    J Clin Endocrinol Metab; 1986 Feb; 62(2):275-9. PubMed ID: 3510223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological significance of active and inactive renin in man.
    Lijnen P; Amery A; Fagard R; Verschueren L
    J Endocrinol; 1980 Apr; 85(1):137-43. PubMed ID: 6993602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.
    Fruncillo RJ; Rotmensch HH; Vlasses PH; Koplin JR; Swanson BN; Ferguson RK
    Eur J Clin Pharmacol; 1985; 28(1):5-9. PubMed ID: 3886401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
    Yasuda G; Shionoiri H; Umemura S; Takasaki I; Ishii M
    Eur J Endocrinol; 1994 Dec; 131(6):582-8. PubMed ID: 7804440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxygen free radical scavenger system intermediates in essential hypertensive patients before and immediately after sublingual captopril administration.
    Schneider R; Iscovitz H; Ilan Z; Bernstein K; Gros M; Iaina A
    Isr J Med Sci; 1990 Sep; 26(9):491-5. PubMed ID: 2228559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects.
    Wisgerhof M; Brown RD
    J Clin Endocrinol Metab; 1979 Jul; 49(1):107-9. PubMed ID: 447808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).
    Honda M; Izumi Y; Kawahara Y; Hatano M
    Jpn Circ J; 1981 Sep; 45(9):1025-9. PubMed ID: 7029028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension.
    Koletsky RJ; Gordon MB; LeBoff MS; Moore TJ; Dluhy RG; Hollenberg NK; Williams GH
    Clin Sci (Lond); 1984 Mar; 66(3):299-305. PubMed ID: 6362960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.